ClinicalTrials.gov
public full text
Public Domain
Impact of Escitalopram on Sperm DNA Fragmentation
Double-blind placebo-controlled randomized trial of daily escitalopram for 6 weeks in healthy men with normal semen analyses and no psychiatric history of depression, bipolar, mania or suicidal ideation. Hormone profiles, semen analysis, sperm DNA fragmentation, and sexual function will be measured at baseline, after 6 weeks of therapy, and 4 weeks after discontinuation of therapy (10 weeks into study).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DNA Fragmentation - Effect on Pregnancy Rate#853970
- Prevalence of high DNA fragmentation index in male partners of unexplained infertile couples.#666009
- Effectiveness of Pretreatment Letrozole Versus Misoprostol Alone in Missed Abortion#852027
- Vaginal Progesterone for the Prevention of Preterm Birth in Twins#1127702
- Millennium Cohort Study: Age 9 months, Sweep 1, 2003: Survey of Mothers who Received Assisted Fertility Treatment#207759
Record · ID 1008063
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive